Stoke Therapeutics

0 followers

‌

Stoke Therapeutics is pioneering a new way to treat the underlying causes of severe genetic diseases by precisely upregulating protein expression.

Industries

Employees

51-200

Links


Org chart

Edward M. Kaye
CEO & Director
Collapse
Dawn Kalmar
Chief Communications Officer
Barry S. Ticho
Chief Medical Officer
Jonathan Allan
General Counsel
Isabel Aznarez
Co-Founder & VP, Discovery Research
Christy Chaves Blaney
Senior Director, Head Of Talent Acquisition
Kimberly Parkerson
Senior Vice President, Head Of Neurology Clinical Development
Lorene Kush
Executive Assistant To Chief Executive Officer
Malini Viswanathan Ph.D
Vice President Portfolio and Alliance Management
Parisa S.
Vice President, Patient Advocacy & Policy
Stephen Yu
VP Head of IT
Jason Hoitt
Chief Patient Officer
Eric Olson
Chief Business Officer
Marissa V.
SVP, Clinical Development Operations
Ken Pirro
Senior Director, Engineering and Facilities
Sherry L.
Executive Director, Regulatory Affairs

Board & advisors